IDA total vs Slovenia: Cause of death, by non-communicable diseases, male
IDA total
39.3%
in 2021
Slovenia
76.6%
in 2021
IDA total rank
37th
Slovenia rank
34th
Cause of death, by non-communicable diseases, male over time
- IDA total
- Slovenia
How they compare
Slovenia currently reports 76.6% against 39.3% in IDA total, a difference of 37.3%.
That makes Slovenia's figure about 1.9 times IDA total's.
Across all 6 years both countries report, Slovenia has been ahead every year.
IDA total ranks 37th and Slovenia ranks 34th of 47 groups.
Slovenia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | IDA total | Slovenia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 28.4% | 84.6% | 56.1% | Slovenia |
| 2010s | 38.8% | 87.7% | 48.8% | Slovenia |
| 2020s | 40.7% | 76.5% | 35.8% | Slovenia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, male, IDA total or Slovenia?
- Slovenia, at 76.6% against 39.3% in IDA total as of 2021.
- What is the difference in cause of death, by non-communicable diseases, male between IDA total and Slovenia?
- 37.3%, with Slovenia ahead.
- How many years of comparable data are there for IDA total and Slovenia?
- 6 years are reported by both, from 2000 to 2021.
- How do IDA total and Slovenia rank globally for cause of death, by non-communicable diseases, male?
- IDA total ranks 37th and Slovenia ranks 34th of 47 groups.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, male (% of total male deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages due to non-communicable diseases divided by number of all male deaths ages, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.